INTERNATIONAL PATENT: HIBERCELL, INC. FILES APPLICATION FOR "METHODS OF TREATING ACUTE MYELOID LEUKEMIA USING COMBINATIONS OF GCN2 MODULATORS, VENETOCLAX AND AZACITIDINE"

GENEVA, June 19 -- HIBERCELL, INC. (619 West 54th Street, 8th FloorNew York, New York 10016) filed a patent application (PCT/US2024/059068) for "METHODS OF TREATING ACUTE MYELOID LEUKEMIA USING COMBINATIONS OF GCN2 MODULATORS, VENETOCLAX, AND AZACITIDINE" on Dec 07, 2024. With publication no. WO/2025/122985, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOSE, Nandita (c/o HiberCell, Inc.619 West 54th Street, 8th FloorNew York, New York 10019), SURGULADZE, David (c/o HiberCell, Inc.619 West 54th Street, 8th FloorNew York...